Trial Profile
Effects of ipragliflozin on body composition and beta-cell function in Japanese patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2017
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 May 2016 New trial record